Lv41
640 积分 2024-01-29 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
20天前
已完结
Management of Testicular Cancer
1个月前
已关闭
Antibody-drug conjugates: A review of cutaneous adverse effects
1个月前
已完结
Dermatologic Toxicities of Antibody-Drug Conjugates
1个月前
已完结
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta‐analysis
1个月前
已完结
Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis
1个月前
已完结
PR031/#1199 Phase I, two-part, mutlicenter, first-in-human (FIH) study of TORL-1–23, a novel claudin 6 (CLDN6) targeting antibody drug conjugate (ADC) in patients with advanced solid tumors
1个月前
已关闭
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
3个月前
已完结
皖公网安备34019202002308
